RNA m6A methylation regulators in ovarian cancer
Abstract N6-methyladenosine (m6A) is the most abundant RNA modification of mammalian mRNAs and plays a vital role in many diseases, especially tumours. In recent years, m6A has become the topic of intense discussion in epigenetics. M6A modification is dynamically regulated by methyltransferases, dem...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8109343cc80e4d1d97e0ce7a290795f2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:8109343cc80e4d1d97e0ce7a290795f2 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:8109343cc80e4d1d97e0ce7a290795f22021-11-21T12:39:36ZRNA m6A methylation regulators in ovarian cancer10.1186/s12935-021-02318-81475-2867https://doaj.org/article/8109343cc80e4d1d97e0ce7a290795f22021-11-01T00:00:00Zhttps://doi.org/10.1186/s12935-021-02318-8https://doaj.org/toc/1475-2867Abstract N6-methyladenosine (m6A) is the most abundant RNA modification of mammalian mRNAs and plays a vital role in many diseases, especially tumours. In recent years, m6A has become the topic of intense discussion in epigenetics. M6A modification is dynamically regulated by methyltransferases, demethylases and RNA-binding proteins. Ovarian cancer (OC) is a common but highly fatal malignancy in female. Increasing evidence shows that changes in m6A levels and the dysregulation of m6A regulators are associated with the occurrence, development or prognosis of OC. In this review, the latest studies on m6A and its regulators in OC have been summarized, and we focus on the key role of m6A modification in the development and progression of OC. Additionally, we also discuss the potential use of m6A modification and its regulators in the diagnosis and treatment of OC.Jialu GuoJianfeng ZhengHuizhi ZhangJinyi TongBMCarticleOvarian cancerBiomarkerN6-methyladenosineRegulatorsNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282CytologyQH573-671ENCancer Cell International, Vol 21, Iss 1, Pp 1-13 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Ovarian cancer Biomarker N6-methyladenosine Regulators Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Cytology QH573-671 |
spellingShingle |
Ovarian cancer Biomarker N6-methyladenosine Regulators Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Cytology QH573-671 Jialu Guo Jianfeng Zheng Huizhi Zhang Jinyi Tong RNA m6A methylation regulators in ovarian cancer |
description |
Abstract N6-methyladenosine (m6A) is the most abundant RNA modification of mammalian mRNAs and plays a vital role in many diseases, especially tumours. In recent years, m6A has become the topic of intense discussion in epigenetics. M6A modification is dynamically regulated by methyltransferases, demethylases and RNA-binding proteins. Ovarian cancer (OC) is a common but highly fatal malignancy in female. Increasing evidence shows that changes in m6A levels and the dysregulation of m6A regulators are associated with the occurrence, development or prognosis of OC. In this review, the latest studies on m6A and its regulators in OC have been summarized, and we focus on the key role of m6A modification in the development and progression of OC. Additionally, we also discuss the potential use of m6A modification and its regulators in the diagnosis and treatment of OC. |
format |
article |
author |
Jialu Guo Jianfeng Zheng Huizhi Zhang Jinyi Tong |
author_facet |
Jialu Guo Jianfeng Zheng Huizhi Zhang Jinyi Tong |
author_sort |
Jialu Guo |
title |
RNA m6A methylation regulators in ovarian cancer |
title_short |
RNA m6A methylation regulators in ovarian cancer |
title_full |
RNA m6A methylation regulators in ovarian cancer |
title_fullStr |
RNA m6A methylation regulators in ovarian cancer |
title_full_unstemmed |
RNA m6A methylation regulators in ovarian cancer |
title_sort |
rna m6a methylation regulators in ovarian cancer |
publisher |
BMC |
publishDate |
2021 |
url |
https://doaj.org/article/8109343cc80e4d1d97e0ce7a290795f2 |
work_keys_str_mv |
AT jialuguo rnam6amethylationregulatorsinovariancancer AT jianfengzheng rnam6amethylationregulatorsinovariancancer AT huizhizhang rnam6amethylationregulatorsinovariancancer AT jinyitong rnam6amethylationregulatorsinovariancancer |
_version_ |
1718418894527397888 |